Literature DB >> 12906376

Biochemical markers of bone metabolism in the assessment of osteoporosis: useful or not?

M J Seibel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12906376     DOI： 10.1007/BF03345204

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  18 in total

Review 1.  Molecular markers of bone turnover: biochemical, technical and analytical aspects.

Authors:  M J Seibel
Journal:  Osteoporos Int       Date:  2000       Impact factor: 4.507

2.  Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density.

Authors:  C H Chesnut; N H Bell; G S Clark; B L Drinkwater; S C English; C C Johnson; M Notelovitz; C Rosen; D F Cain; K A Flessland; N J Mallinak
Journal:  Am J Med       Date:  1997-01       Impact factor: 4.965

Review 3.  Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy.

Authors:  B L Riggs; L J Melton; W M O'Fallon
Journal:  Bone       Date:  1996-03       Impact factor: 4.398

4.  Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study.

Authors:  P L van Daele; M J Seibel; H Burger; A Hofman; D E Grobbee; J P van Leeuwen; J C Birkenhäger; H A Pols
Journal:  BMJ       Date:  1996-02-24

5.  Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis.

Authors:  D Thiébaud; P Burckhardt; H Kriegbaum; H Huss; H Mulder; J R Juttmann; K H Schöter
Journal:  Am J Med       Date:  1997-10       Impact factor: 4.965

6.  Rapid bone loss is associated with increased levels of biochemical markers.

Authors:  P D Ross; W Knowlton
Journal:  J Bone Miner Res       Date:  1998-02       Impact factor: 6.741

7.  Prevention of early postmenopausal bone loss with cyclical etidronate therapy (a double-blind, placebo-controlled study and 1-year follow-up)

Authors:  P J Meunier; E Confavreux; I Tupinon; C Hardouin; P D Delmas; R Balena
Journal:  J Clin Endocrinol Metab       Date:  1997-09       Impact factor: 5.958

8.  Biochemical markers of bone turnover reflect femoral bone loss in elderly women.

Authors:  R Dresner-Pollak; R A Parker; M Poku; J Thompson; M J Seibel; S L Greenspan
Journal:  Calcif Tissue Int       Date:  1996-11       Impact factor: 4.333

9.  Urinary hydroxypyridinium crosslinks of collagen in population-based screening for overt vertebral osteoporosis: results of a pilot study.

Authors:  M J Seibel; H Woitge; C Scheidt-Nave; G Leidig-Bruckner; A Duncan; P Nicol; R Ziegler; S P Robins
Journal:  J Bone Miner Res       Date:  1994-09       Impact factor: 6.741

10.  Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: a retrospective and prospective population-based study of women.

Authors:  K Akesson; S Ljunghall; B Jonsson; I Sernbo; O Johnell; P Gärdsell; K J Obrant
Journal:  J Bone Miner Res       Date:  1995-11       Impact factor: 6.741
View more
  5 in total

1.  Plasma levels of C-telopeptide pyridinoline cross-links of type I collagen and osteocalcin in chronic periodontitis.

Authors:  Ozgün Ozçaka; Ayşe Nalbantsoy; Nurgün Bıçakçı; Timur Köse; Nurcan Buduneli
Journal:  Inflammation       Date:  2011-06       Impact factor: 4.092

2.  Estimation of serum osteocalcin and telopeptide-C in postmenopausal osteoporotic females.

Authors:  M Lateef; M Baig; A Azhar
Journal:  Osteoporos Int       Date:  2009-07-14       Impact factor: 4.507

Review 3.  Metabolomics and Its Application in the Development of Discovering Biomarkers for Osteoporosis Research.

Authors:  Huanhuan Lv; Feng Jiang; Daogang Guan; Cheng Lu; Baosheng Guo; Chileung Chan; Songlin Peng; Baoqin Liu; Wenwei Guo; Hailong Zhu; Xuegong Xu; Aiping Lu; Ge Zhang
Journal:  Int J Mol Sci       Date:  2016-12-02       Impact factor: 5.923

4.  Assessing bone mineral changes in response to vitamin D supplementation using natural variability in stable isotopes of Calcium in Urine.

Authors:  Ravi Rangarajan; Surajit Mondal; Prashanth Thankachan; Ramananda Chakrabarti; Anura V Kurpad
Journal:  Sci Rep       Date:  2018-11-13       Impact factor: 4.379

Review 5.  Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club.

Authors:  P Bergmann; J-J Body; S Boonen; Y Boutsen; J-P Devogelaer; S Goemaere; J-M Kaufman; J-Y Reginster; V Gangji
Journal:  Int J Clin Pract       Date:  2009-01       Impact factor: 2.503
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.